Establishment Net Receivables vs Cash Analysis
ESTA Stock | USD 58.81 2.62 4.66% |
Establishment Labs financial indicator trend analysis is much more than just examining Establishment Labs latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Establishment Labs is a good investment. Please check the relationship between Establishment Labs Net Receivables and its Cash accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Net Receivables vs Cash
Net Receivables vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Establishment Labs Net Receivables account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between Establishment Labs' Net Receivables and Cash is 0.72. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Cash in the same time period over historical financial statements of Establishment Labs Holdings, assuming nothing else is changed. The correlation between historical values of Establishment Labs' Net Receivables and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Establishment Labs Holdings are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Net Receivables i.e., Establishment Labs' Net Receivables and Cash go up and down completely randomly.
Correlation Coefficient | 0.72 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Receivables
Cash
Cash refers to the most liquid asset of Establishment Labs, which is listed under current asset account on Establishment Labs Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Establishment Labs customers. The amounts must be unrestricted with restricted cash listed in a different Establishment Labs account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Establishment Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. The current year's Tax Provision is expected to grow to about 3.4 M, whereas Selling General Administrative is forecasted to decline to about 74 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 85.4M | 106.6M | 107.0M | 58.1M | Total Revenue | 126.7M | 161.7M | 165.2M | 92.0M |
Establishment Labs fundamental ratios Correlations
Click cells to compare fundamentals
Establishment Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Establishment Labs fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 20.5M | 23.3M | 24.0M | 24.5M | 25.6M | 21.8M | |
Total Assets | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Short Long Term Debt Total | 48.1M | 51.8M | 53.8M | 178.7M | 192.2M | 201.8M | |
Other Current Liab | 11.8M | 14.0M | 16.2M | 16.5M | 12.9M | 14.5M | |
Total Current Liabilities | 23.2M | 25.9M | 31.9M | 39.0M | 57.2M | 30.6M | |
Total Stockholder Equity | 39.6M | 75.0M | 50.7M | (8.2M) | 18.4M | 29.4M | |
Other Liab | 5.5M | 3.8M | 3.1M | 1.6M | 1.5M | 1.4M | |
Net Tangible Assets | 35.7M | 70.3M | 45.9M | (13.3M) | (15.2M) | (14.5M) | |
Property Plant And Equipment Net | 16.4M | 18.8M | 20.9M | 54.8M | 80.6M | 84.6M | |
Current Deferred Revenue | 785K | 1.2M | 769K | 1.7M | 1.8M | 1.5M | |
Net Debt | 10.5M | (32.8M) | 391K | 112.3M | 152.2M | 159.8M | |
Retained Earnings | (127.1M) | (165.2M) | (206.4M) | (281.6M) | (360.1M) | (342.1M) | |
Accounts Payable | 10.4M | 9.7M | 14.5M | 20.0M | 41.6M | 43.7M | |
Cash | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Non Current Assets Total | 20.7M | 24.1M | 26.3M | 61.2M | 93.7M | 98.4M | |
Non Currrent Assets Other | 368K | 664K | 558K | 1.3M | 4.7M | 4.9M | |
Other Assets | 368K | 664K | 558K | 1.3M | 1.5M | 785.7K | |
Cash And Short Term Investments | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Net Receivables | 22.8M | 19.1M | 24.4M | 35.4M | 46.9M | 25.6M | |
Common Stock Total Equity | 147.7M | 213.5M | 219.7M | 223.6M | 257.2M | 156.9M | |
Liabilities And Stockholders Equity | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Non Current Liabilities Total | 53.7M | 55.5M | 56.9M | 180.3M | 193.1M | 202.8M | |
Capital Surpluse | 21.2M | 26.7M | 36.6M | 49.9M | 57.4M | 60.3M | |
Inventory | 28.7M | 23.2M | 28.4M | 36.6M | 79.9M | 83.9M | |
Other Current Assets | 1.3M | 2.6M | 2.6M | 11.5M | 8.0M | 4.6M | |
Other Stockholder Equity | 18.4M | 23.9M | 33.7M | 47.1M | 60.9M | 63.9M | |
Total Liab | 76.9M | 81.4M | 88.8M | 219.2M | 250.2M | 262.8M | |
Property Plant And Equipment Gross | 16.4M | 18.8M | 20.9M | 54.8M | 96.9M | 101.8M | |
Total Current Assets | 95.8M | 132.3M | 113.3M | 149.9M | 174.9M | 112.4M | |
Accumulated Other Comprehensive Income | 691K | 2.9M | 3.7M | 2.7M | 2.0M | 1.5M | |
Non Current Liabilities Other | 336K | 2.3M | 2.4M | 175.5M | 147K | 139.7K | |
Short Term Debt | 258K | 948K | 402K | 688K | 773K | 734.4K | |
Intangible Assets | 3.4M | 4.1M | 4.4M | 4.6M | 8.0M | 4.6M | |
Common Stock | 147.7M | 213.5M | 219.7M | 223.6M | 315.6M | 180.7M | |
Property Plant Equipment | 16.4M | 16.2M | 20.9M | 51.1M | 58.8M | 61.7M | |
Long Term Debt | 48.1M | 49.8M | 51.9M | 175.5M | 188.7M | 198.2M | |
Net Invested Capital | 87.8M | 124.8M | 102.6M | 175.5M | 207.1M | 127.1M | |
Net Working Capital | 72.6M | 106.4M | 81.4M | 110.9M | 117.8M | 87.1M |
Pair Trading with Establishment Labs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.Moving together with Establishment Stock
0.62 | CI | Cigna Corp | PairCorr |
0.76 | DXCM | DexCom Inc | PairCorr |
0.83 | EDAP | EDAP TMS SA Earnings Call Tomorrow | PairCorr |
Moving against Establishment Stock
0.79 | DRIO | DarioHealth Corp Earnings Call Today | PairCorr |
0.69 | HUM | Humana Inc Financial Report 7th of August 2024 | PairCorr |
0.59 | CNC | Centene Corp Sell-off Trend | PairCorr |
0.58 | FONR | Fonar Earnings Call This Week | PairCorr |
0.57 | PMD | Psychemedics | PairCorr |
The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.
The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.17) | Revenue Per Share 6.451 | Quarterly Revenue Growth (0.28) | Return On Assets (0.17) | Return On Equity (15.38) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.